Quality of life – Survey

Quality of life – Survey

  Results from the survey “Quality-of-life”, patients with neuroendocrine tumors (NET)1. The survey gathered information on the NET patient experience, including diagnosis, disease impact and management, quality of life, and knowledge and awareness levels.   Quality...
Quality of life – at ENETS

Quality of life – at ENETS

  Results from the global survey “Quality-of-life”, patients with neuroendocrine tumors (NET)1. Presented at ENETS, European Neuroendocrine Tumor Society, in Barcelona. NET Cancer patient experience, including diagnosis, disease impact and management, quality of life,...
Global NET patient survey

Global NET patient survey

The International Neuroendocrine Cancer Alliance (INCA) and Novartis presents the quality-of-life results from the first global survey of patients with neuroendocrine tumors (NETs), a rare type of cancer1. Nearly 2,000 patients from 12 countries completed the survey,...